Work

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Final Five-Year Outcomes From the Randomized BIOFLOW-V Trial

Year: 2022

Type: article

Source: Cardiovascular revascularization medicine

DOI: 10.1016/j.carrev.2022.06.187

Authors: David E. Kandzari, Jacques J. Koolen, Gheorghe Doros, Hector M. Garcia-Garcia, Johan Bennett, Ariel Roguin, Elie G. Gharib, Donald E. Cutlip, Ron Waksman

Institutions: Piedmont Atlanta Hospital, Catharina Ziekenhuis, Boston University, Baim Institute for Clinical Research, MedStar Washington Hospital Center, Universitair Ziekenhuis Leuven, Hillel Yaffe Medical Center, Charleston Area Medical Center, Beth Israel Deaconess Medical Center

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4298294611

FWCI:

Cites:

Cited by:

Related to: 10